Concepedia

Huamao Wang

HW

40

Publications

2.5K

Citations

23

H-Index

2004

Active since

Affiliations

State Key Laboratory of Oncogene and Related Genes(Current)

Shanghai Cancer Institute

Renji Hospital

Shanghai Jiao Tong University

University of Kent

Huamao Wang is an author at State Key Laboratory of Oncogene and Related Genes specializing in medicine, business, and finance.

ORCID

Top concepts

Publications per year

2004–2023

40

Publications

40

Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results

Changsong Qi, Jifang Gong, Jian Li et al. · Nature Medicine · 2022 · 527 citations · Full text

Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials

Donghua Shi, Ahmed O. Kaseb, Xingxing Qi et al. · Clinical Cancer Research · 2020 · 340 citations

Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer

Hua Jiang, Zhimin Shi, Peng Wang et al. · JNCI Journal of the National Cancer Institute · 2018 · 230 citations

Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3–Targeted Chimeric Antigen Receptor–Engineered T Cells in Hepatocellular Carcinoma

Ying Liu, Shengmeng Di, Bizhi Shi et al. · The Journal of Immunology · 2019 · 134 citations

Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma

Cheng Chen, Kesang Li, Hua Jiang et al. · Cancer Immunology Immunotherapy · 2016 · 107 citations · Full text

, , +8

Rows per page

1–5 of 40